Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, opened its state-of-the-art radiopharmaceutical manufacturing facility. The 27,000 sq.-ft. GMP compliant facility, located adjacent to the company’s R&D labs, has clinical and commercial manufacturing scale capabilities designed to support the Company’s growing pipeline of targeted alpha therapies (TATs). “Manufacturing and supply chain...